These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11848541)

  • 1. Treatment of unresectable malignant abdominal, pelvic and thoracic tumors using abdominal pelvic and thoracic stop-flow chemotherapy.
    Chrysos E; Tsiaoussis J; Alexandra K; Athanasakis H; Tsetis D; Varveris C; Fiorentini G; Lucchi SR; Vassilakis JS; Zoras O
    Anticancer Res; 2001; 21(5):3669-75. PubMed ID: 11848541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal and pelvic stop-flow chemotherapy. Effect of chemotherapeutic agents and tissue ischemia on rectoanal pressures.
    Chrysos E; Athanasakis E; Vrekousis T; Almarashdah S; Fiorentini G; Xynos E; Zoras O
    J Exp Clin Cancer Res; 2006 Sep; 25(3):303-8. PubMed ID: 17167968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings.
    Miotto D; Miotto D; Bertolo S; Minante M; Darisi T; Mocellin S; Casara D; Ori C; Foletto M; Rossi CR; Lise M; Nitti D
    J Chemother; 2004 Nov; 16 Suppl 5():44-7. PubMed ID: 15675477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial.
    van Ijken MG; van Etten B; Guetens G; de Bruijn EA; Ten Hagen TL; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):897-904. PubMed ID: 16084053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
    Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D'Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
    Eur J Surg Oncol; 2004 Aug; 30(6):663-70. PubMed ID: 15256242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of flow-controlled antiblastic perfusions (stop-flow technique) carried out with percutaneous technique: 30-month experience].
    Roversi R; Ricci S; Rossi G; Cavallo G; Roversi M; Fiorentini G
    Radiol Med; 1997 Jun; 93(6):732-8. PubMed ID: 9411522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
    van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aortic stop flow and hypoxic perfusion chemotherapy for unresectable gallbladder cancer].
    Aoki T; Tsuchida A; Aoki T; Asami K; Uda O; Inoue K; Masuhara S; Kasuya K; Ozawa T; Koyanagi Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):115-8. PubMed ID: 9464337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Caterino GP; Di Giuro G; Amicucci G
    Eur J Surg Oncol; 2007 Feb; 33(1):72-8. PubMed ID: 17166688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications and toxicity after abdominal and pelvic hypoxic stop-flow perfusion chemotherapy: incidence and assessment of risk factors.
    de Bree E; Romanos J; Tsogkas J; Askoxylakis J; Metaxari M; Michalakis J; Volakakis E; Melissas J; Tsiftsis DD
    Ann Surg Oncol; 2012 Oct; 19(11):3591-7. PubMed ID: 22576062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineoplastic perfusion with percutaneous stop-flow control in the treatment of advanced pelvic malignant neoplasms].
    De Santis M; Ariosi P; Calò GF; Luppi G; Franchini M; Romagnoli R
    Radiol Med; 2000; 100(1-2):56-61. PubMed ID: 11109453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic perfusion for locally recurrent unresectable rectal tumors.
    Unal AE; Bayar S; Tez M; Gocmen E; Kocaoglu H; Akgul H
    Hepatogastroenterology; 2005; 52(63):757-60. PubMed ID: 15966199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic variations during thoracic and abdominal stop-flow regional chemotherapy.
    Varrassi G; Guadagni S; Ciccozzi A; Marinangeli F; Pozone T; Piroli A; Marsili I; Paladini A
    Eur J Surg Oncol; 2004 May; 30(4):377-83. PubMed ID: 15063890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
    Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
    Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hypoxic stop-flow perfusion and high dose chemotherapy in the treatment of regionally advanced colorectal cancer.
    Di Giorgio A; Franchi F; Di Seri M; Lacava V; Caroli S; Russo GE; Borzomati V; Al Mansour M
    J Chemother; 1997 Dec; 9(6):436-41. PubMed ID: 9491845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma.
    Maruo T; Motoyama S; Hamana S; Yoshida S; Ohara N; Yamasaki M; Ku Y
    Surg Oncol Clin N Am; 2008 Oct; 17(4):843-56, x. PubMed ID: 18722922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.
    Wanebo HJ; DiSiena M; Begossi G; Belliveau J; Gustafson E
    Ann Surg Oncol; 2008 Apr; 15(4):1107-16. PubMed ID: 18157578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.